Neogen Chemicals Limited
₹2,179.35-₹84.30 (-3.7%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹3,443 Cr
- P/E
- 69.7x
- EV / EBITDA
- 29.5x
- Revenue
- ₹774 Cr
- Net margin
- 5.8%
- ROCE
- 9.9%
Price chart
Technical chartScreen technicals →+48.5% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -11.0%
- 3M
- +9.5%
- 6M
- +33.5%
- 1Y
- +48.5%
- 5Y
- +73.1%
52-week range
Day change -₹84.30 (-3.7%) from ₹2,264 to ₹2,179 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in NEOGEN, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Strong 5-year revenue CAGR of 18.0%
Concerns1
- Low return on equity of 5.4%
Rule-based from financial data. Not advice.
About the company
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India.
Read moreShow less
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, specialty polymers, vapor absorption chillers, emerging battery material applications, and other industries. The company also exports its products to 33 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.
- Sector
- Materials
- Shares outstanding
- 2.6 Cr shares
- ISIN
- INE136S01016
- BSE code
- 542665
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹3,443 Cr
- P/E
- 69.7x
- P/B
- 4.1x
- EV / EBITDA
- 29.5x
- EV / Sales
- 5.2x
- P/S
- 4.9x
- Earnings yield
- 1.4%
- 52-week high
- ₹2,697.45
- 52-week low
- ₹980.00
Profitability
- Operating margin
- 16.5%
- Net margin
- 5.8%
- EBITDA margin
- 17.7%
- ROE
- 5.4%
- ROCE
- 9.9%
- ROA
- 2.9%
- Dividend payout
- 13.0%
- Tax rate
- 31.0%
- Other income, % of PBT
- 13.6%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹774 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 10.4%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 18.0%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹124 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 6.0%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 17.1%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 7.2%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -₹134 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 346.7%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -₹2.00 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 33.3%
Solvency and efficiency
- Current ratio
- 4.30
- Debt / Equity
- 0.53
- Debt / Assets
- 0.29
- Debt / EBITDA
- 3.30
- Interest coverage
- 2.76
- Financial leverage
- 1.83
- CFO / Net profit
- -3.27
- Cash / Market cap
- 28.6%
- Cash per share
- ₹371.73
- Asset turnover
- 0.50
- Fixed asset turnover
- 1.94
- Capital intensity
- 0.51
- Debtor days
- 147 days
- Inventory turnover
- 1.03
- Cash conversion cycle
- 366 days
Where the revenue went
FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.
| Line | FY2025 |
|---|---|
| Sales | ₹774 Cr |
| Expenses | ₹627 Cr |
| Operating profit | ₹147 Cr |
| Other income | -₹4 Cr |
| Interest | ₹51 Cr |
| Depreciation | ₹26 Cr |
| Profit before tax | ₹66 Cr |
| Tax and other | ₹18 Cr |
| Net profit | ₹48 Cr |
Revenue and net profit
Revenue grew 10.4% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹336 Cr | ₹31 Cr |
| FY2022 | ₹487 Cr | ₹45 Cr |
| FY2023 | ₹686 Cr | ₹50 Cr |
| FY2024 | ₹701 Cr | ₹41 Cr |
| FY2025 | ₹774 Cr | ₹48 Cr |
Cash flows
FY2025: ₹199 Cr from operations, ₹11.0 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹83 Cr | -₹51 Cr |
| FY2022 | ₹1 Cr | -₹145 Cr |
| FY2023 | -₹30 Cr | -₹124 Cr |
| FY2024 | -₹134 Cr | -₹263 Cr |
| FY2025 | ₹199 Cr | ₹11 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹774 Cr+10.4%1Y
- Net profit
- ₹48 Cr+17.1%1Y
- Cash from operations
- ₹199 Cr
- Free cash flow
- ₹11 Cr
- Revenue CAGR, 5Y
- 18.0%
- EBITDA CAGR, 5Y
- 16.4%
- Net profit CAGR, 5Y
- 7.2%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹774 Cr | ₹147 Cr | — | ₹48 Cr | ₹199 Cr | ₹11 Cr | 5.9% | +10.4% | +17.1% |
Monthly returns
Month-by-month returns of NEOGEN across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹1,621 Cr |
| Equity capital | ₹26 Cr |
| Reserves | ₹782 Cr |
| Borrowings | ₹474 Cr |
| Other liabilities | ₹338 Cr |
| Assets | ₹1,621 Cr |
| Fixed assets | ₹228 Cr |
| Capital work in progress | ₹28 Cr |
| Investments | ₹193 Cr |
| Other assets | ₹1,173 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
NEOGEN trades at 69.7x earnings against a peer median of 35.5x (a 97% premium).
Not shown (no positive earnings and no EV / Sales): BN AGROCHEM LIMITED.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Neogen Chemicals LimitedNEOGENthis companyP/E ↑ premium | ₹3,443 Cr | 69.7x | 4.1x | 5.4% | 29.5x |
| Foseco India LtdFOSECOIND | ₹3,548 Cr | 43.0x | 8.1x | — | — |
| Gujarat Alkalis & Chemicals Ltd.GUJALKALI | ₹3,537 Cr | 65.5x | 0.6x | -2.1% | 17.0x |
| Vishnu Chemicals LimitedVISHNU | ₹3,484 Cr | 46.8x | 4.2x | 14.9% | 20.6x |
| ORIENT CEMENT LIMITEDORIENTCEM | ₹3,400 Cr | 11.1x | 1.6x | 10.0% | 7.4x |
| BN AGROCHEM LIMITEDBNAGROCHEM | ₹3,398 Cr | — | 10.6x | -4.2% | -1133.0x |
| Styrenix Performance Materials LimitedSTYRENIX | ₹3,375 Cr | 16.3x | 3.8x | — | — |
| Grauer & Weil (India) Ltd.GRAUWEIL | ₹3,354 Cr | 22.2x | 3.4x | 17.9% | 14.7x |
| Refex Industries LimitedREFEX | ₹3,314 Cr | 16.4x | 2.3x | 21.4% | 20.2x |
| Peer median | — | 35.5x | 3.7x | 12.9% | 19.2x |
Year-to-date ROI
NEOGEN since 1 January, against earlier years.
Historical volatility
NEOGEN's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 19.0% |
| FY2022 | 18.0% |
| FY2023 | 16.0% |
| FY2024 | 17.0% |
| FY2025 | 19.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹774 Cr |
| Costs | |
| Interest | ₹51 Cr |
| Expenses | ₹627 Cr |
| Operating profitOperating Profit | ₹147 Cr |
| Other income and charges | |
| Profit before tax | ₹66 Cr |
| Tax | |
| Net profitNet Profit | ₹48 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹1,621 Cr |
| Equity capitalEquity Capital | ₹26 Cr |
| Reserves | ₹782 Cr |
| Borrowings | ₹474 Cr |
| Other liabilitiesOther Liabilities | ₹338 Cr |
| AssetsTotal Assets | ₹1,621 Cr |
| Fixed assetsFixed Assets | ₹228 Cr |
| Capital work in progressCWIP | ₹28 Cr |
| Investments | ₹193 Cr |
| Other assetsOther Assets | ₹1,173 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹199 Cr |
| Investing cash flowCash from Investing Activity | -₹188 Cr |
| Financing cash flowCash from Financing Activity | -₹12 Cr |
| Change in cashNet Cash Flow | -₹2 Cr |
Learn while you research
Academy chapters picked for Neogen Chemicals Limited and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 69.7, learn when high multiples are justified.6 min read
- 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 05 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read